EPCAM and cancer: We assessed that the cancer cells in 23 of 26 samples are highly EpCAM‐positive, with more than 50% cancer cells expressing this epithelial marker (average from all samples = 80.4%; 95% CI = 0.003) and exhibiting more epithelial phenotype based on their positive MET score.